COVID drugs

We are approaching the two-year anniversary of the Emergency Use Authorization (EUA) of Paxlovid, the most effective COVID-19 antiviral drug.

If there is a single lesson to be learned from three years of the pandemic, it's that if you're going to try to treat Covid with a drug, it had better be a direct-acting antiviral drug. (1)

In a new article in Nature, author Max Kozlov asks the question, "COVID drug Paxlovi

I recently wrote an article comparing the availability and use of the two newly approved anti-COVID drugs (1) Paxlovid and molnupiravir. Bottom line: Doctors and patients voted with their scripts.

The good news? There's a very effective antiviral drug called Paxlovid that will keep you alive and out of the hospital when/if omicron gets you, and a second drug, molnupiravir, which doesn't work as well, but can still be helpful. The bad news?

As Professor Katherine Radtke-Seley and I wrote last year in the Baltimore Sun, vaccines

Back in April, I wrote about EIDD-2801, now called molnupiravir, (1) at which time I wr

Six months ago it seemed that every other lab had a kick-ass, re-purposed drug that was only weeks away from putting the hurt on COVID. How did that work out?